Paper37814076
Plasma cell signatures predict prognosis and treatment efficacy for lung adenocarcinoma.
Shu L and 3 others. Cell Oncol (Dordr), 2024. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Plasma cell signatures predict prognosis and treatment efficacy for lung adenocarcinoma. Papers, record 37814076. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37814076
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma of Lung | Major topic |
| Lung Neoplasms | Major topic |
| Plasma Cells | Major topic |
| Humans | |
| Prognosis | |
| Male | |
| Female | |
| Middle Aged | |
| Treatment Outcome | |
| Gene Expression Regulation, Neoplastic | |
| Aged | |
| Cell Line, Tumor | |
| Biomarkers, Tumor | |
| Nomograms |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82073097 | National Natural Science Foundation of China | PubMed | ||
| 82072594 | National Natural Science Foundation of China | PubMed | ||
| 2021SK2013 | Natural Science Foundation of Hunan Province, and Hunan Provincial Key Area R&D Programs | PubMed | ||
| 2022RC3072 | The Science and Technology Innovation Program of Hunan Province | PubMed |
Source PubMed
References90
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29130882 | Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. | Elife | 2017 | https://conductscience.org/library/papers/29130882 | PubMed |
| 2 | 31988391 | B cells, plasma cells and antibody repertoires in the tumour microenvironment. | Nat Rev Immunol | 2020 | https://conductscience.org/library/papers/31988391 | PubMed |
| 3 | 33005833 | Inhibition of furin by bone targeting superparamagnetic iron oxide nanoparticles alleviated breast cancer bone metastasis. | Bioact Mater | 2021 | https://conductscience.org/library/papers/33005833 | PubMed |
| 4 | 31942071 | Tertiary lymphoid structures improve immunotherapy and survival in melanoma. | Nature | 2020 | https://conductscience.org/library/papers/31942071 | PubMed |
| 5 | 30327690 | Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer. | Dis Markers | 2018 | https://conductscience.org/library/papers/30327690 | PubMed |
| 6 | 36633525 | Cancer statistics, 2023. | CA Cancer J Clin | 2023 | https://conductscience.org/library/papers/36633525 | PubMed |
| 7 | 33552145 | A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune Biomarkers. | Front Genet | 2020 | https://conductscience.org/library/papers/33552145 | PubMed |
| 8 | 33533160 | Combining bioinformatics analysis and experiments to explore CARNS1 as a prognostic biomarker for breast cancer. | Mol Genet Genomic Med | 2021 | https://conductscience.org/library/papers/33533160 | PubMed |
| 9 | 26477306 | Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma. | Oncogene | 2016 | https://conductscience.org/library/papers/26477306 | PubMed |
| 10 | 30049748 | Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer. | Clin Cancer Res | 2018 | https://conductscience.org/library/papers/30049748 | PubMed |
| 11 | 35938142 | Genomic and Immunological Characterization of Pyroptosis in Lung Adenocarcinoma. | J Oncol | 2022 | https://conductscience.org/library/papers/35938142 | PubMed |
| 12 | 36934264 | Exosomal MFI2-AS1 sponge miR-107 promotes non-small cell lung cancer progression through NFAT5. | Cancer Cell Int | 2023 | https://conductscience.org/library/papers/36934264 | PubMed |
| 13 | 31094023 | Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis. | Cell Prolif | 2019 | https://conductscience.org/library/papers/31094023 | PubMed |
| 14 | 33824268 | CAR-T cell therapy: current limitations and potential strategies. | Blood Cancer J | 2021 | https://conductscience.org/library/papers/33824268 | PubMed |
| 15 | 36347994 | KLF15 suppresses tumor growth and metastasis in Triple-Negative Breast Cancer by downregulating CCL2 and CCL7. | Sci Rep | 2022 | https://conductscience.org/library/papers/36347994 | PubMed |
| 16 | 27798871 | Radiotherapy-associated Furin Expression and Tumor Invasiveness in Recurrent Laryngeal Cancer. | Anticancer Res | 2016 | https://conductscience.org/library/papers/27798871 | PubMed |
| 17 | 30228364 | Molecular pathogenesis of triple-negative breast cancer based on microRNA expression signatures: antitumor miR-204-5p targets AP1S3. | J Hum Genet | 2018 | https://conductscience.org/library/papers/30228364 | PubMed |
| 18 | 35267511 | Role of Furin in Colon Cancer Stem Cells Malignant Phenotype and Expression of LGR5 and NANOG in KRAS and BRAF-Mutated Colon Tumors. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35267511 | PubMed |
| 19 | 32389711 | Loss of the proprotein convertase Furin in T cells represses mammary tumorigenesis in oncogene-driven triple negative breast cancer. | Cancer Lett | 2020 | https://conductscience.org/library/papers/32389711 | PubMed |
| 20 | 33127882 | The membrane-bound and soluble form of melanotransferrin function independently in the diagnosis and targeted therapy of lung cancer. | Cell Death Dis | 2020 | https://conductscience.org/library/papers/33127882 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41948338 | CLIC6 and ANLN: novel exosome-related prognostic markers and therapeutic targets in lung adenocarcinoma. | Front Immunol | 2026 | https://conductscience.org/library/papers/41948338 | PubMed |
| 41522114 | Tumor prognostic risk stratification based on pseudo-time analysis of single-cell sequencing for patients with lung adenocarcinoma. | J Thorac Dis | 2025 | https://conductscience.org/library/papers/41522114 | PubMed |
| 41142627 | CLIC6's role in cancer: from broad analysis to breast cancer validation. | Front Oncol | 2025 | https://conductscience.org/library/papers/41142627 | PubMed |
| 40843931 | Comprehensive analysis of the leukocyte immunoglobulin-like receptor family in clear cell renal cell carcinoma. | Ann Med | 2025 | https://conductscience.org/library/papers/40843931 | PubMed |
| 40591124 | Decoding breast cancer heterogeneity: a novel three-gene signature links intratumoral heterogeneity with tumor microenvironment and patient outcomes. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40591124 | PubMed |
| 40568599 | Risk scoring model for lung adenocarcinoma based on PD-L1 related signature reveals prognostic predictability and correlation with tumor immune microenvironment genes was constructed. | Front Immunol | 2025 | https://conductscience.org/library/papers/40568599 | PubMed |
| 40360749 | The role of B cell immunity in lung adenocarcinoma. | Genes Immun | 2025 | https://conductscience.org/library/papers/40360749 | PubMed |
| 40264416 | Single-cell transcriptomic data reveal the cellular heterogeneity of glutamine metabolism in gastric premalignant lesions and early gastric cancer. | Acta Biochim Biophys Sin (Shanghai) | 2025 | https://conductscience.org/library/papers/40264416 | PubMed |
| 40134565 | Chloride intracellular channel 6 inhibits hepatocellular carcinoma progression by modulating immune cell balance and promoting tumor cell apoptosis. | Cytojournal | 2025 | https://conductscience.org/library/papers/40134565 | PubMed |
| 40095490 | A Glycolysis and gluconeogenesis-related model for breast cancer prognosis. | Cancer Biomark | 2024 | https://conductscience.org/library/papers/40095490 | PubMed |
| 40029549 | Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancer. | Cell Oncol (Dordr) | 2025 | https://conductscience.org/library/papers/40029549 | PubMed |
| 39991572 | Intercellular Adhesion Molecule 3: Structure, Cellular Functions, and Emerging Role in Human Diseases. | J Cancer | 2025 | https://conductscience.org/library/papers/39991572 | PubMed |
| 39843484 | Integrative analysis of single-cell and transcriptome sequencing with experimental validation reveals PKHD1L1 as a novel biomarker in lung adenocarcinoma. | Sci Rep | 2025 | https://conductscience.org/library/papers/39843484 | PubMed |
| 39744696 | B cells and tertiary lymphoid structures in tumors: immunity cycle, clinical impact, and therapeutic applications. | Theranostics | 2025 | https://conductscience.org/library/papers/39744696 | PubMed |
| 39119106 | A glycolysis-related signature to improve the current treatment and prognostic evaluation for breast cancer. | PeerJ | 2024 | https://conductscience.org/library/papers/39119106 | PubMed |
| 38963643 | The Novel-B-Cell-Related Gene Signature Predicts the Prognosis and Immune Status of Patients with Esophageal Carcinoma. | J Gastrointest Cancer | 2024 | https://conductscience.org/library/papers/38963643 | PubMed |
| 38854627 | Identification of a Prognostic Model Based on NK Cell-Related Genes in Multiple Myeloma Using Single-Cell and Transcriptomic Data Analysis. | Blood Lymphat Cancer | 2024 | https://conductscience.org/library/papers/38854627 | PubMed |
| 38071320 | Circadian rhythm-associated lncRNA RP11-414H17.5 as a key therapeutic target in osteosarcoma affects the tumor immune microenvironment and enhances malignancy. | J Orthop Surg Res | 2023 | https://conductscience.org/library/papers/38071320 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37814076
GET https://conductscience.org/api/papers/v1/37814076/references?page=2